Nasser Ghaly Yousif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nasser Ghaly Yousif has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Al muthanna medical college
4 shared publications- Maitham Ghaly Yousif
Biology Department, College of Science University of Al-Qadisiyah
4 shared publications - Bassim I. Mohammad
Department of Pharmacology and Therapeutics, College of Medicine, University of Al-Qadisiyah, Al-Qadisiyah
3 shared publications - Fadhil G. Al-Amran
Surgical Department, Medical College, Kufa University, Najaf, Iraq
3 shared publications Najah Hadi
3 shared publicationsAbdallah Ali Deb
Colorado University, Aurora, CO
2 shared publications
Latest Publications
- Open Access
- 15 March 2025
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 13 (1) , 35-51
Therapeutic Applications of Bone Marrow-Derived Stem Cells in Avascular Necrosis of the Hip Current Evidence and Future Directions
Avascular necrosis (AVN) of the hip is a debilitating condition predominantly affecting young adults, often leading to femoral head collapse and early joint replacement. Recent advances in regenerative medicine have highlighted the potential of bone marrow-derived stem cell therapy as a disease-modifying intervention. In this prospective study, 50 patients (mean age 38.5 years) with early to mid-stage AVN of the hip underwent autologous bone marrow-derived stem cell implantation. Patients were followed for 18 months, with clinical outcomes assessed using the Harris Hip Score (HHS), Visual Analog Scale (VAS) for pain, WOMAC, and SF-36 quality of life metrics. Subgroup analyses were performed by AVN stage. Significant improvements were observed across all clinical parameters. Mean HHS increased from 65.3 at baseline to 85.4 at 18 months (p<0.001), while mean VAS pain scores decreased from 7.8 to 2.8 (p<0.001). WOMAC scores improved from 65.2 to 30.2, and SF-36 domains showed an average 35% enhancement. Hip preservation was achieved in 90% of cases, with the greatest benefit seen in early-stage disease. No major complications or adverse events were reported. In conclusion, autologous bone marrow-derived stem cell therapy is a safe and effective treatment for early to mid-stage AVN of the hip, resulting in substantial pain relief, functional recovery, and improved quality of life. These findings support the integration of cellular therapy into standard AVN management protocols and underscore the need for further multicenter, long-term studies.
- 15 March 2025
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 13 (1) , 35-51
Open AccessTherapeutic Applications of Bone Marrow-Derived Stem Cells in Avascular Necrosis of the Hip Current Evidence and Future Directions
Avascular necrosis (AVN) of the hip is a debilitating condition predominantly affecting young adults, often leading to femoral head collapse and early joint replacement. Recent advances in regenerative medicine have highlighted the potential of bone marrow-derived stem cell therapy as a disease-modifying intervention. In this prospective study, 50 patients (mean age 38.5 years) with early to mid-stage AVN of the hip underwent autologous bone marrow-derived stem cell implantation. Patients were followed for 18 months, with clinical outcomes assessed using the Harris Hip Score (HHS), Visual Analog Scale (VAS) for pain, WOMAC, and SF-36 quality of life metrics. Subgroup analyses were performed by AVN stage. Significant improvements were observed across all clinical parameters. Mean HHS increased from 65.3 at baseline to 85.4 at 18 months (p<0.001), while mean VAS pain scores decreased from 7.8 to 2.8 (p<0.001). WOMAC scores improved from 65.2 to 30.2, and SF-36 domains showed an average 35% enhancement. Hip preservation was achieved in 90% of cases, with the greatest benefit seen in early-stage disease. No major complications or adverse events were reported. In conclusion, autologous bone marrow-derived stem cell therapy is a safe and effective treatment for early to mid-stage AVN of the hip, resulting in substantial pain relief, functional recovery, and improved quality of life. These findings support the integration of cellular therapy into standard AVN management protocols and underscore the need for further multicenter, long-term studies.
- 28 February 2025
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 41 (3) , 310-323
Role of Vitamin-E as a Vital Nutrient in Health and Diseases
Vitamin E, known for its antioxidant properties, has been studied extensively for its potential health benefits, particularly in mitigating skin and overall health complications. The skin serves as a crucial barrier against environmental stressors and oxidative damage. Vitamin E, comprising tocopherols and tocotrienols, acts as a potent antioxidant, scavenging free radicals that contribute to skin aging, inflammation, and diseases. Studies have demonstrated that Vitamin E supplementation can enhance skin health by protecting against UV-induced damage, improving moisture retention, and promoting wound healing. These effects are attributed to its ability to stabilize cell membranes and modulate inflammatory responses, thereby supporting skin integrity and function. Beyond dermatological benefits, Vitamin E supplementation shows promise in improving overall health outcomes. Research suggests that Vitamin E may reduce cardiovascular risk by inhibiting oxidative modification of lipoproteins and enhancing endothelial function. Moreover, it has been associated with potential benefits in neuroprotection, immune modulation, and management of chronic diseases such as diabetes and arthritis. These systemic effects are mediated through its antioxidant and anti-inflammatory properties, which contribute to cellular health and function. However, the effectiveness of Vitamin E supplementation can vary based on several factors, including dosage, formulation, and individual health status. High doses of Vitamin E, in particular, have raised concerns regarding adverse effects and interactions with medications. Therefore, careful consideration of dosage and monitoring of health outcomes are essential in clinical settings. In conclusion, Vitamin E supplementation holds promise in ameliorating skin and health complications through its antioxidant and anti-inflammatory actions. While evidence supports its beneficial effects on skin integrity, wound healing, and systemic health markers, further research is warranted to elucidate optimal dosage regimens and long-term safety profiles. Clinicians and researchers alike should continue to explore Vitamin E’s potential in personalized medicine approaches, aiming to optimize health outcomes while minimizing risks associated with supplementation. This paper will elucidate the multifaceted role of Vitamin E in promoting skin health and overall well-being, highlighting its potential as a therapeutic adjunct in dermatology, cancer, infertility, heart diseases and preventive medicine. Future research endeavors should focus on refining supplementation protocols and expanding our understanding of Vitamin E’s mechanisms of action across various health conditions.
- 28 February 2025
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 41 (3) , 310-323
Role of Vitamin-E as a Vital Nutrient in Health and Diseases
Vitamin E, known for its antioxidant properties, has been studied extensively for its potential health benefits, particularly in mitigating skin and overall health complications. The skin serves as a crucial barrier against environmental stressors and oxidative damage. Vitamin E, comprising tocopherols and tocotrienols, acts as a potent antioxidant, scavenging free radicals that contribute to skin aging, inflammation, and diseases. Studies have demonstrated that Vitamin E supplementation can enhance skin health by protecting against UV-induced damage, improving moisture retention, and promoting wound healing. These effects are attributed to its ability to stabilize cell membranes and modulate inflammatory responses, thereby supporting skin integrity and function. Beyond dermatological benefits, Vitamin E supplementation shows promise in improving overall health outcomes. Research suggests that Vitamin E may reduce cardiovascular risk by inhibiting oxidative modification of lipoproteins and enhancing endothelial function. Moreover, it has been associated with potential benefits in neuroprotection, immune modulation, and management of chronic diseases such as diabetes and arthritis. These systemic effects are mediated through its antioxidant and anti-inflammatory properties, which contribute to cellular health and function. However, the effectiveness of Vitamin E supplementation can vary based on several factors, including dosage, formulation, and individual health status. High doses of Vitamin E, in particular, have raised concerns regarding adverse effects and interactions with medications. Therefore, careful consideration of dosage and monitoring of health outcomes are essential in clinical settings. In conclusion, Vitamin E supplementation holds promise in ameliorating skin and health complications through its antioxidant and anti-inflammatory actions. While evidence supports its beneficial effects on skin integrity, wound healing, and systemic health markers, further research is warranted to elucidate optimal dosage regimens and long-term safety profiles. Clinicians and researchers alike should continue to explore Vitamin E’s potential in personalized medicine approaches, aiming to optimize health outcomes while minimizing risks associated with supplementation. This paper will elucidate the multifaceted role of Vitamin E in promoting skin health and overall well-being, highlighting its potential as a therapeutic adjunct in dermatology, cancer, infertility, heart diseases and preventive medicine. Future research endeavors should focus on refining supplementation protocols and expanding our understanding of Vitamin E’s mechanisms of action across various health conditions.
- Open Access
- 6 January 2025
- Published by Scientific Scholar in Journal of Hematology and Allied Sciences
- p. 1-7
CAR-T therapy and allogeneic stem cell transplantation for refractory acute myeloid leukemia: A comparative study
Children with chemo-refractory acute myeloid leukemia (AML) have a poor prognosis and a high frequency of relapsed and/or refractory AML, with a poor result of hematopoietic stem cell transplantation (HSCT). An external major histocompatibility antigens-independent antigen-binding domain, a transmembrane-linking domain, and an intracellular costimulatory T-cell signaling domain or numerous domains make up chimeric antigen receptor T lymphocytes (CARTs). By specifically targeting CD19, CART have proved effective in improving therapy results for B-lineage acute lymphoblastic leukemia. AML is defined as the absence of a myeloid counterpart to CD19, or a “expendable” antigen. Occasionally, AML will produce the T-cell antigen CD7, which anti-CD7 CAR-T-cells can target to destroy CD7-bearing T-cells. In conclusion; myeloid antigen-directed CART-cell therapy might cause remission in AML patients who are not responding to treatment and myeloid antigen-directed CAR-T therapy can be used as a bridge to allogeneic HSCT in r/r AML.
- 6 January 2025
- Published by Scientific Scholar in Journal of Hematology and Allied Sciences
- p. 1-7
Open AccessCAR-T therapy and allogeneic stem cell transplantation for refractory acute myeloid leukemia: A comparative study
Children with chemo-refractory acute myeloid leukemia (AML) have a poor prognosis and a high frequency of relapsed and/or refractory AML, with a poor result of hematopoietic stem cell transplantation (HSCT). An external major histocompatibility antigens-independent antigen-binding domain, a transmembrane-linking domain, and an intracellular costimulatory T-cell signaling domain or numerous domains make up chimeric antigen receptor T lymphocytes (CARTs). By specifically targeting CD19, CART have proved effective in improving therapy results for B-lineage acute lymphoblastic leukemia. AML is defined as the absence of a myeloid counterpart to CD19, or a “expendable” antigen. Occasionally, AML will produce the T-cell antigen CD7, which anti-CD7 CAR-T-cells can target to destroy CD7-bearing T-cells. In conclusion; myeloid antigen-directed CART-cell therapy might cause remission in AML patients who are not responding to treatment and myeloid antigen-directed CAR-T therapy can be used as a bridge to allogeneic HSCT in r/r AML.
- Open Access
- 2 May 2024
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 12 (2) , 52-58
Therapeutic use of autologous hematopoietic bone marrow transplant combined with concentrated platelet in infected surgical wounds: single-center prospective study
The healing wound is the consecutive process of maintaining tissue integrity including inflammatory, proliferative, and remodeling processes. Stem cells can self-renew, and also to differentiate into all cell types, and are involved in physiological regeneration, use of mesenchymal stem cells deriving from the bone marrow with PRP has potentiated the healing process. We conducted a single-arm pilot prospective analytical study was performed on 15 patients whose mean age was 31 years (range: 29–51 years), with refractory abdominal wounds at a private hospital in Iraq from March 30, 2022, to March 2023. Ten days after the stem cell transplant the re-enforcement with PRP subcutaneous injection around wounds. Small papules of granulation tissue appeared over the wound, and tissue granulation increased from 80% (30.26–80.00%) to 100% (81–100%). At the same time, the wound size was reduced by 60% (52.10–78.23%). The follow-up period was 7–24 months, during which no recurrence of the wound was found. In conclusion, the current study is the first to characterize the safety and efficacy of bone marrow-derived stem cells in combination with PRP in the treatment of refractory abdominal wound infection. All patients achieved a 100% healing rate in a short time, and no treatment-related adverse reactions occurred during the treatment.
- 2 May 2024
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 12 (2) , 52-58
Open AccessTherapeutic use of autologous hematopoietic bone marrow transplant combined with concentrated platelet in infected surgical wounds: single-center prospective study
The healing wound is the consecutive process of maintaining tissue integrity including inflammatory, proliferative, and remodeling processes. Stem cells can self-renew, and also to differentiate into all cell types, and are involved in physiological regeneration, use of mesenchymal stem cells deriving from the bone marrow with PRP has potentiated the healing process. We conducted a single-arm pilot prospective analytical study was performed on 15 patients whose mean age was 31 years (range: 29–51 years), with refractory abdominal wounds at a private hospital in Iraq from March 30, 2022, to March 2023. Ten days after the stem cell transplant the re-enforcement with PRP subcutaneous injection around wounds. Small papules of granulation tissue appeared over the wound, and tissue granulation increased from 80% (30.26–80.00%) to 100% (81–100%). At the same time, the wound size was reduced by 60% (52.10–78.23%). The follow-up period was 7–24 months, during which no recurrence of the wound was found. In conclusion, the current study is the first to characterize the safety and efficacy of bone marrow-derived stem cells in combination with PRP in the treatment of refractory abdominal wound infection. All patients achieved a 100% healing rate in a short time, and no treatment-related adverse reactions occurred during the treatment.
- Open Access
- 30 December 2023
- Published by Al-Muthanna University in Muthanna Medical Journal
- Vol. 10 (2)
Therapeutic use of hematopoietic mesenchymal stem cells in osteoarthritis: a meta-analysis study
- 30 December 2023
- Published by Al-Muthanna University in Muthanna Medical Journal
- Vol. 10 (2)
Open AccessTherapeutic use of hematopoietic mesenchymal stem cells in osteoarthritis: a meta-analysis study
- Open Access
- 30 September 2023
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 11 (3) , 144-157
Increased neutrophil-lymphocyte ratio in patients with COPD: case-control study
Chronic obstructive pulmonary disease (COPD) is one of the major causes of chronic morbidity and mortality and one of the major public health problems worldwide that affects millions of people all over the world. It is characterized by persistent airflow obstruction associated with enhanced inflammation in the airways and the lungs in response to noxious particles or gases. The main objective of this study is to investigate the neutrophil-lymphocyte ratio in patients with COPD as a case-control study. Between November 01, 2022, and February 28, 2023, patients were admitted to Al Hussain Teaching Hospital in Al Muthanna Governorate, Department of Medicine. The study included 51 patients with an approved diagnosis of COPD the mean age was 51.5 years, and 51 patients as control with other diseases mean age was 51.3 years). The subjects in all groups were 32 male and 19 female. Complete blood count (CBC) was measured from blood samples taken from patients. In the present study 51 COPD cases and 51 controls. No significant difference was observed between COPD cases and controls regarding age (p = 0.092); the average age of COPD cases was 51.5 years. No significant differences were observed between COPD cases and controls regarding gender (p = 0.085). At baseline, 21.0%, 40.3%, 25.7%, and 13% were diagnosed as COPD grade 1, 2, 3, and 4, respectively based on the (GOLD) classification. Baseline NLR significantly increased with the severity of COPD grade (1.3 vs. 2.7 vs. 2.2 vs. 2.9), p = 0.002). The cutoff for neutrophil-to-lymphocyte ratio, CRP, WBC, and ESR were 3.28, 2.32, 1.22, and 4.21 respectively. It has 85% sensitivity for detection of COPD exacerbation. and 89% specificity (AUC 0.798, p = 0.001). In conclusion, Blood NLR is a simple, inexpensive, widely available index that has been intensively evaluated in recent years in several clinical applications and in various diseases, including COPD.
- 30 September 2023
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 11 (3) , 144-157
Open AccessIncreased neutrophil-lymphocyte ratio in patients with COPD: case-control study
Chronic obstructive pulmonary disease (COPD) is one of the major causes of chronic morbidity and mortality and one of the major public health problems worldwide that affects millions of people all over the world. It is characterized by persistent airflow obstruction associated with enhanced inflammation in the airways and the lungs in response to noxious particles or gases. The main objective of this study is to investigate the neutrophil-lymphocyte ratio in patients with COPD as a case-control study. Between November 01, 2022, and February 28, 2023, patients were admitted to Al Hussain Teaching Hospital in Al Muthanna Governorate, Department of Medicine. The study included 51 patients with an approved diagnosis of COPD the mean age was 51.5 years, and 51 patients as control with other diseases mean age was 51.3 years). The subjects in all groups were 32 male and 19 female. Complete blood count (CBC) was measured from blood samples taken from patients. In the present study 51 COPD cases and 51 controls. No significant difference was observed between COPD cases and controls regarding age (p = 0.092); the average age of COPD cases was 51.5 years. No significant differences were observed between COPD cases and controls regarding gender (p = 0.085). At baseline, 21.0%, 40.3%, 25.7%, and 13% were diagnosed as COPD grade 1, 2, 3, and 4, respectively based on the (GOLD) classification. Baseline NLR significantly increased with the severity of COPD grade (1.3 vs. 2.7 vs. 2.2 vs. 2.9), p = 0.002). The cutoff for neutrophil-to-lymphocyte ratio, CRP, WBC, and ESR were 3.28, 2.32, 1.22, and 4.21 respectively. It has 85% sensitivity for detection of COPD exacerbation. and 89% specificity (AUC 0.798, p = 0.001). In conclusion, Blood NLR is a simple, inexpensive, widely available index that has been intensively evaluated in recent years in several clinical applications and in various diseases, including COPD.
- Open Access
- 30 July 2023
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 11 (3) , 110-123
System dynamics analysis of mortality post allogeneic hematopoietic stem cell transplant
- 30 July 2023
- Published by BM-Publisher American Journal of BioMedicine in American Journal of BioMedicine
- Vol. 11 (3) , 110-123
Open AccessSystem dynamics analysis of mortality post allogeneic hematopoietic stem cell transplant
- Open Access
Prevalence and Associated Factors of Human Papillomavirus Infection among Iraqi Women
Human papillomavirus (HPV) is a significant public health concern, as it is a leading cause of cervical cancer in women. However, data on the prevalence of HPV infection among Iraqi women is scarce. This study aimed to estimate the prevalence of HPV infection and its associated factors among Iraqi women aged 15-50 attending health centers. In this cross-sectional study, 362 female participants aged 15-50 were recruited from health centers in Iraq. Serological tests were used to screen for HPV infection. Sociodemographic information, obstetric history, and contraceptive use were collected. Pap smears were performed to assess cervical changes related to HPV infection. Of the 362 participants, 65 (17.96%) tested positive for HPV. The majority of HPV-positive women were aged 30-35 years, housewives, and belonged to lower social classes. Among HPV-positive women, 30% had abnormal Pap smears, with 55% diagnosed with cervical intraepithelial neoplasia grade 1 (CIN1), 25% with CIN2, and 15% with CIN3. Biopsy confirmed the diagnosis in 5% of cases. No significant association was found between HPV infection and contraceptive use. Most HPV-positive women were multiparous. This study reveals a considerable prevalence of HPV infection among Iraqi women attending health centers, particularly in the age group of 30-35 years and among housewives. These findings highlight the need for targeted public health interventions to increase HPV awareness, promote regular screening, and improve access to healthcare services for women, especially those from lower social classes. Further research is warranted to better understand the factors contributing to HPV transmission in Iraq and to develop effective prevention strategies.
Open AccessPrevalence and Associated Factors of Human Papillomavirus Infection among Iraqi Women
Human papillomavirus (HPV) is a significant public health concern, as it is a leading cause of cervical cancer in women. However, data on the prevalence of HPV infection among Iraqi women is scarce. This study aimed to estimate the prevalence of HPV infection and its associated factors among Iraqi women aged 15-50 attending health centers. In this cross-sectional study, 362 female participants aged 15-50 were recruited from health centers in Iraq. Serological tests were used to screen for HPV infection. Sociodemographic information, obstetric history, and contraceptive use were collected. Pap smears were performed to assess cervical changes related to HPV infection. Of the 362 participants, 65 (17.96%) tested positive for HPV. The majority of HPV-positive women were aged 30-35 years, housewives, and belonged to lower social classes. Among HPV-positive women, 30% had abnormal Pap smears, with 55% diagnosed with cervical intraepithelial neoplasia grade 1 (CIN1), 25% with CIN2, and 15% with CIN3. Biopsy confirmed the diagnosis in 5% of cases. No significant association was found between HPV infection and contraceptive use. Most HPV-positive women were multiparous. This study reveals a considerable prevalence of HPV infection among Iraqi women attending health centers, particularly in the age group of 30-35 years and among housewives. These findings highlight the need for targeted public health interventions to increase HPV awareness, promote regular screening, and improve access to healthcare services for women, especially those from lower social classes. Further research is warranted to better understand the factors contributing to HPV transmission in Iraq and to develop effective prevention strategies.
- Open Access
Post-COVID-19 Effects on Female Fertility: An In-Depth Scientific Investigation
This study aimed to comprehensively investigate the post-COVID-19 effects on female fertility in patients with a history of severe COVID-19 infection. Data were collected from 340 patients who had previously experienced severe COVID-19 symptoms and sought medical assistance at private clinics and fertility centers in various provinces of Iraq. A comparative control group of 280 patients, who had not contracted COVID-19 or had mild cases, was included. The study assessed ovarian reserve, hormonal imbalances, and endometrial health in the post-recovery phase. The findings revealed a significant decrease in ovarian reserve, hormonal disturbances, and endometrial abnormalities among patients with a history of severe COVID-19 infection compared to the control group. This in-depth investigation sheds light on the potential long-term impacts of severe COVID-19 on female fertility. The results emphasize the need for further research and targeted interventions to support women affected by post-COVID-19 fertility issues. Understanding these effects is crucial for providing appropriate medical care and support to women on their reproductive journey after recovering from severe COVID-19.
Open AccessPost-COVID-19 Effects on Female Fertility: An In-Depth Scientific Investigation
This study aimed to comprehensively investigate the post-COVID-19 effects on female fertility in patients with a history of severe COVID-19 infection. Data were collected from 340 patients who had previously experienced severe COVID-19 symptoms and sought medical assistance at private clinics and fertility centers in various provinces of Iraq. A comparative control group of 280 patients, who had not contracted COVID-19 or had mild cases, was included. The study assessed ovarian reserve, hormonal imbalances, and endometrial health in the post-recovery phase. The findings revealed a significant decrease in ovarian reserve, hormonal disturbances, and endometrial abnormalities among patients with a history of severe COVID-19 infection compared to the control group. This in-depth investigation sheds light on the potential long-term impacts of severe COVID-19 on female fertility. The results emphasize the need for further research and targeted interventions to support women affected by post-COVID-19 fertility issues. Understanding these effects is crucial for providing appropriate medical care and support to women on their reproductive journey after recovering from severe COVID-19.
- Open Access
- 4 December 2022
- Published by Al-Muthanna University in Muthanna Medical Journal
Discrepancies association between FLT3 inhibitors use and prognosis of acute myeloid leukemia: systematic review and meta-analysis
Acute myeloid leukemia (AML) is a malignancy of proliferative, clonal, abnormally, or poorly differentiated cells of the hematopoietic system, characterized by clonal evolution and genetic heterogeneity. Mutations of the FMS-like tyrosine kinase 3 (FLT3) gene occur in approximately 30% of all AML cases, with the internal tandem duplication (ITD) representing the most common type of FLT3 mutation. FLT3-ITD is a common driver mutation that presents with a high leukemic burden and confers a poor prognosis in patients with AML. In this systematic review and meta-analysis, we present a detailed review of current clinical evidence of FLT3 inhibitors and their use in AML, and discrepancies association between FLT3 inhibitors use and prognosis of acute myeloid leukemia and maintenance setting.
- 4 December 2022
- Published by Al-Muthanna University in Muthanna Medical Journal
Open AccessDiscrepancies association between FLT3 inhibitors use and prognosis of acute myeloid leukemia: systematic review and meta-analysis
Acute myeloid leukemia (AML) is a malignancy of proliferative, clonal, abnormally, or poorly differentiated cells of the hematopoietic system, characterized by clonal evolution and genetic heterogeneity. Mutations of the FMS-like tyrosine kinase 3 (FLT3) gene occur in approximately 30% of all AML cases, with the internal tandem duplication (ITD) representing the most common type of FLT3 mutation. FLT3-ITD is a common driver mutation that presents with a high leukemic burden and confers a poor prognosis in patients with AML. In this systematic review and meta-analysis, we present a detailed review of current clinical evidence of FLT3 inhibitors and their use in AML, and discrepancies association between FLT3 inhibitors use and prognosis of acute myeloid leukemia and maintenance setting.